Endocrinology

The endocrinology specialty group was set up within the Department of Internal Medicine in 1972, and the Department of Endocrinology was formally established in 1994. Fu Guorong, Hong Xu and Yuan Mingxia have served as its directors in succession. After decades of accumulation and development, the Department of Endocrinology of Beijing Friendship Hospital has become a modern center for the diagnosis and treatment of endocrine and metabolic diseases integrating care, teaching, research and prevention. Clinical care: guided by the hospital motto of benevolence, excellence and dedication, and adhering to a patient-centered service philosophy, the department provides high-quality medical services. It has a highly qualified and skilled team of doctors and nurses, including several renowned experts and professors as well as young and middle-aged physicians with rich clinical experience; all physicians hold doctoral degrees. At present, 39 beds are open and annual outpatient visits approach 150,000. The scope of care covers common endocrine and metabolic diseases, including diabetes, thyroid diseases, obesity, hypothalamic and pituitary diseases, adrenal diseases, resistant hypertension, lipid metabolism disorders, hyperuricemia and osteoporosis, and the department has a mature and well-established system for standardized diagnosis, assessment, prevention and treatment. Its specialty is the comprehensive prevention, treatment and management of diabetes and obesity-related metabolic diseases; it has set up several expert clinics for specific diseases, a diabetes care clinic and a multidisciplinary (MDT) obesity clinic. With strong expert resources, complete technical facilities, standardized pathways and outstanding clinical advantages, the department has been rated an advanced unit of the hospital for many consecutive years, and its medical quality indicators remain at the forefront in Beijing. Teaching: the department hosts doctoral and master's training programs and a postdoctoral workstation, undertakes graduate training for Capital Medical University, as well as theoretical teaching and clinical teaching for five-year, long-track and international college programs; it is a Beijing standardized training base for internal medicine residents and a clinical teaching base for diabetes health education nurses in Beijing; it organizes national and municipal continuing medical education projects; it hosts the branded Friendship Forum on Obesity and Metabolic Diseases; and it recruits visiting physicians from across the country, training specialists and diabetes education nurses for medical institutions nationwide. Research: the team has long carried out basic and clinical research in endocrine and metabolic diseases, with key directions focusing on obesity and glucose-lipid metabolism, and on the pathogenesis, prevention and management of diabetes and its chronic complications. Professor Yuan Mingxia, the discipline leader, is a national committee member and deputy head of the Obesity Group of the Chinese Diabetes Society, a national committee member of the Endocrinology and Metabolism Branch of the Chinese Medical Doctor Association, and vice chair of the Diabetes Branch of the Beijing Medical Association. She has led the team in presiding over and participating in many national and provincial or ministerial projects, including key projects of the National Natural Science Foundation of China, the Beijing Natural Science Foundation, the Beijing Municipal Health Development Research Special Program, chronic disease management research projects of the National Health Commission, and Beijing postdoctoral research projects. As the lead unit, the department is responsible for developing specialized diabetes clinics in community health service institutions for the Beijing Municipal Health Commission. It has published many high-quality academic papers and edited monographs such as the Endocrinology Section of the Handbook of Internal Medicine, the Practical Manual of Endocrine Ward Orders and the Manual for Prevention and Treatment of Cardiovascular-Renal-Metabolic Syndrome. Department members have taken part as principal writers and expert panel members in the drafting of more than 10 guidelines and expert consensuses. As a clinical pharmacology base recognized by the National Medical Products Administration (NMPA), the department has undertaken and completed a number of drug clinical trials, and its research projects have won multiple patents and science and technology awards. The department has always given equal weight to medical quality and humanistic care, actively strengthening discipline building and improving the overall strength of the team. Guided by the hospital's three-campus-one-division development plan and its comprehensive advantages, and focusing on the clinical difficulties in preventing and treating diabetes, obesity and related metabolic diseases, the team applies information-based and intelligent innovative technologies to provide patients with high-quality care and contribute to the Healthy China initiative.